Wednesday, April 4, 2012

Sorafenib


HCC tumors are generally chemoresistant, and only one
drug—sorafenib, a multikinase inhibitor—
is currently approved for advanced HCC patients.
Posted by Dr Dhanesh Vijayan at Wednesday, April 04, 2012
Labels: ,

No comments:

Post a Comment

Please add your comments or suggestions here..

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)
Related Posts Plugin for WordPress, Blogger...